Durable efficacy of alemtuzumab in CARE-MS II patients with highly active relapsing-remitting multiple sclerosis: 4-year outcomes
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Durable efficacy of alemtuzumab in CARE-MS II patients with highly active relapsing-remitting multiple sclerosis: 4-year outcomes |
Type de publication | Journal Article |
Year of Publication | 2015 |
Auteurs | Krieger S., Freedman M.S, Moreau T., Havrdova E., Selmaj K.W, Margolin D.H, Kasten L., Investigators CARE-MSII |
Journal | MULTIPLE SCLEROSIS JOURNAL |
Volume | 21 |
Pagination | 573 |
Date Published | SEP |
Type of Article | Meeting Abstract |
ISSN | 1352-4585 |